Search results
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 6 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 6 days agoThe two randomised, multi-centre, placebo-controlled trials investigated depemokimab in adults and adolescents with severe asthma with type 2...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 6 days ago, opens new tab experimental drug met its primary goal of reducing asthma attacks in a late-stage...
What's Going With Sanofi Stock On Wednesday? - Sanofi (NASDAQ:SNY)
Benzinga· 4 days agoThe data showed that treatment with oral rilzabrutinib at both high and low doses led to a numerical...
GSK Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- Update
Market Watch· 6 days agoBy Najat Kantouar and Helena Smolak GSK's experimental drug for asthma met its goals in the latest trial, moving a treatment with potential blockbuster sales...
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 5 days agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks· 5 days agoGSK's depemokimab has the potential to become the first ultra-long-acting biologic for severe asthma with a six-month dosing schedule
GSK finds success in severe asthma drug trials
Becker’s Hospital Review· 6 days agoThe drug candidate, depemokimab, was measured in severe asthma patients with Type 2 inflammation characterized by blood eosinophil count, GSK said in a ...
Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen
Medical Xpress· 5 days agoIn the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via AOL· 6 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...
